Further findings would expand our understanding of mechanisms involved in obesity-related disorders mediated by the macrophage-FOXO3 axis, help us identify key regulators of other metabolic disorders and develop individualized treatment options. This evidence concerns the gene FOXO3 and Other metabolic disease.